Xdemvy

FDA Approves Xdemvy: Breakthrough for Eyelid Disease

Tarsus’ Xdemvy is approved by the FDA as the first therapy for common eyelid illness

SG Tylor

Source – Tarsus Pharmaceuticals Tarsus Pharmaceuticals has achieved a groundbreaking milestone with the FDA approval of Xdemvy, the first-ever treatment ...